CLICS Archive
Dashboard
Bill Archiver
Bill Runs
Bill Archives
Bills
Schedules
Schedule Runs
Schedules
Committees
Committee Runs
Committees
Meeting Runs
Meetings
Legislators
Legislator Runs
Legislators
Settings
Back to Archives
Archive #50310
Metadata
Bill Number
SB26-140
HTTP Status
200
Valid JSON
Valid
Archived At
2026-04-01 15:31:03 MDT
Created At
2026-04-01 15:31:03 MDT
Parsed JSON
{ "votes": [], "active": "T", "origin": "Senate", "lls_num": "26-0737", "session": "2026A", "subject": [ "Insurance" ], "bill_num": "SB26-140", "sponsors": [ { "id": "LG004", "title": "Representative", "s_type": "Prime Sponsor", "chamber": "House", "full_name": "Lindsay Gilchrist", "last_name": "Gilchrist", "first_name": "Lindsay", "sponsor_order": "3" }, { "id": "DJ003", "title": "Representative", "s_type": "Prime Sponsor", "chamber": "House", "full_name": "Dusty Johnson", "last_name": "Johnson", "first_name": "Dusty", "sponsor_order": "4" }, { "id": "MB002", "title": "Representative", "s_type": "Additional Sponsor", "chamber": "House", "full_name": "Mary Bradfield", "last_name": "Bradfield", "first_name": "Mary" }, { "id": "AH001", "title": "Representative", "s_type": "Additional Sponsor", "chamber": "House", "full_name": "Anthony Hartsook", "last_name": "Hartsook", "first_name": "Anthony" }, { "id": "JJ002", "title": "Representative", "s_type": "Additional Sponsor", "chamber": "House", "full_name": "Junie Joseph", "last_name": "Joseph", "first_name": "Junie" }, { "id": "RT001", "title": "Representative", "s_type": "Additional Sponsor", "chamber": "House", "full_name": "Rick Taggart", "last_name": "Taggart", "first_name": "Rick" }, { "id": "LF001", "title": "Senator", "s_type": "Prime Sponsor", "chamber": "Senate", "full_name": "Lisa Frizell", "last_name": "Frizell", "first_name": "Lisa", "sponsor_order": "1" }, { "id": "JM004", "title": "Senator", "s_type": "Prime Sponsor", "chamber": "Senate", "full_name": "Janice Marchman", "last_name": "Marchman", "first_name": "Janice", "sponsor_order": "2" }, { "id": "JA002", "title": "Senator", "s_type": "Additional Sponsor", "chamber": "Senate", "full_name": "Judy Amabile", "last_name": "Amabile", "first_name": "Judy" }, { "id": "SB004", "title": "Senator", "s_type": "Additional Sponsor", "chamber": "Senate", "full_name": "Scott Bright", "last_name": "Bright", "first_name": "Scott" }, { "id": "JC004", "title": "Senator", "s_type": "Additional Sponsor", "chamber": "Senate", "full_name": "John Carson", "last_name": "Carson", "first_name": "John" }, { "id": "IJ001", "title": "Senator", "s_type": "Additional Sponsor", "chamber": "Senate", "full_name": "Iman Jodeh", "last_name": "Jodeh", "first_name": "Iman" }, { "id": "BK001", "title": "Senator", "s_type": "Additional Sponsor", "chamber": "Senate", "full_name": "Barbara Kirkmeyer", "last_name": "Kirkmeyer", "first_name": "Barbara" }, { "id": "CS001", "title": "Senator", "s_type": "Additional Sponsor", "chamber": "Senate", "full_name": "Cleave Simpson", "last_name": "Simpson", "first_name": "Cleave" } ], "bill_files": [ { "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/FBBE1124A20DD3BE87258D7E00618525/$File/140_01.pdf", "date": "03/16/2026", "label": "Introduced", "url_html": "", "lastModified": "03/16/2026 11:25:39 AM" } ], "committees": [ { "id": "S_HHS_2026A", "name": "Health & Human Services", "chamber": "Senate" } ], "long_title": "Concerning exempting certain drugs from the scope of affordability reviews conducted by the Colorado prescription drug affordability review board.", "bill_status": "In Committee - SEN Health & Human Services", "short_title": "Exempt Drugs from Rx Drug Affordability Bd Reviews", "bill_summary": "<html><body><p> The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, a prescription drug that is:<br/></p><p><ul><li>Designated as a drug for a rare disease or condition by the food and drug administration (FDA) of the federal department of health and human services; or</li><li>A licensed biological product that is derived from human whole blood or plasma as indicated on product labeling approved by the FDA.<i>(Note: This summary applies to this bill as introduced.)</i></p></body></html>", "progress_bar": [ { "end": "F", "label": "Introduced", "position": 1 }, { "end": "F", "label": "Under Consideration", "position": 2 } ], "special_type": "", "bill_category": "Health and Environment", "allow_testimony": "F", "amendment_files": [], "full_bill_topic": "Exempt Drugs from Prescription Drug Affordability Board Reviews", "long_bill_files": [], "GHG_report_files": [], "preamended_files": [], "bill_sub_category": "Disease Control", "fiscal_note_files": [ { "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/FBBE1124A20DD3BE87258D7E00618525/$File/SB140_00.pdf", "date": "03/17/2026", "label": "FN1", "url_html": "", "lastModified": "03/17/2026 04:20:37 PM", "label_detailed": "Initial Fiscal Note" }, { "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/FBBE1124A20DD3BE87258D7E00618525/$File/SB140_r1.pdf", "date": "04/01/2026", "label": "FN2", "url_html": "", "lastModified": "04/01/2026 03:10:33 PM", "label_detailed": "First Revised Fiscal Note" } ], "is_budget_package": "No", "session_laws_files": "", "summarized_history": [ { "date": "03/16/2026", "action": "Introduced In Senate - Assigned to Health & Human Services", "location": "Senate" } ], "research_note_files": [], "bill_sub_sub_category": "Health Disparities Treatment Programs", "committee_report_files": [], "demographic_note_files": [], "updated_bill_summary_files": [], "budget_staff_analysis_files": [], "first_chamber_third_reading_date": "", "second_chamber_third_reading_date": "" }
Raw Response
{"bill_num":"SB26-140","lls_num":"26-0737","origin":"Senate","short_title":"Exempt Drugs from Rx Drug Affordability Bd Reviews","full_bill_topic":"Exempt Drugs from Prescription Drug Affordability Board Reviews","long_title":"Concerning exempting certain drugs from the scope of affordability reviews conducted by the Colorado prescription drug affordability review board.","special_type":"","bill_category":"Health and Environment","bill_sub_category":"Disease Control","bill_sub_sub_category":"Health Disparities Treatment Programs","is_budget_package":"No","subject":["Insurance"],"bill_status":"In Committee - SEN Health & Human Services","sponsors":[{"id":"LG004","title":"Representative","first_name":"Lindsay","last_name":"Gilchrist","full_name":"Lindsay Gilchrist","s_type":"Prime Sponsor","chamber":"House","sponsor_order":"3"},{"id":"DJ003","title":"Representative","first_name":"Dusty","last_name":"Johnson","full_name":"Dusty Johnson","s_type":"Prime Sponsor","chamber":"House","sponsor_order":"4"},{"id":"MB002","title":"Representative","first_name":"Mary","last_name":"Bradfield","full_name":"Mary Bradfield","s_type":"Additional Sponsor","chamber":"House"},{"id":"AH001","title":"Representative","first_name":"Anthony","last_name":"Hartsook","full_name":"Anthony Hartsook","s_type":"Additional Sponsor","chamber":"House"},{"id":"JJ002","title":"Representative","first_name":"Junie","last_name":"Joseph","full_name":"Junie Joseph","s_type":"Additional Sponsor","chamber":"House"},{"id":"RT001","title":"Representative","first_name":"Rick","last_name":"Taggart","full_name":"Rick Taggart","s_type":"Additional Sponsor","chamber":"House"},{"id":"LF001","title":"Senator","first_name":"Lisa","last_name":"Frizell","full_name":"Lisa Frizell","s_type":"Prime Sponsor","chamber":"Senate","sponsor_order":"1"},{"id":"JM004","title":"Senator","first_name":"Janice","last_name":"Marchman","full_name":"Janice Marchman","s_type":"Prime Sponsor","chamber":"Senate","sponsor_order":"2"},{"id":"JA002","title":"Senator","first_name":"Judy","last_name":"Amabile","full_name":"Judy Amabile","s_type":"Additional Sponsor","chamber":"Senate"},{"id":"SB004","title":"Senator","first_name":"Scott","last_name":"Bright","full_name":"Scott Bright","s_type":"Additional Sponsor","chamber":"Senate"},{"id":"JC004","title":"Senator","first_name":"John","last_name":"Carson","full_name":"John Carson","s_type":"Additional Sponsor","chamber":"Senate"},{"id":"IJ001","title":"Senator","first_name":"Iman","last_name":"Jodeh","full_name":"Iman Jodeh","s_type":"Additional Sponsor","chamber":"Senate"},{"id":"BK001","title":"Senator","first_name":"Barbara","last_name":"Kirkmeyer","full_name":"Barbara Kirkmeyer","s_type":"Additional Sponsor","chamber":"Senate"},{"id":"CS001","title":"Senator","first_name":"Cleave","last_name":"Simpson","full_name":"Cleave Simpson","s_type":"Additional Sponsor","chamber":"Senate"}],"committees":[{"id":"S_HHS_2026A","chamber":"Senate","name":"Health & Human Services"}],"first_chamber_third_reading_date":"","second_chamber_third_reading_date":"","summarized_history":[{"date":"03/16/2026","location":"Senate","action":"Introduced In Senate - Assigned to Health & Human Services"}],"progress_bar":[{"position":1,"label":"Introduced","end":"F"},{"position":2,"label":"Under Consideration","end":"F"}],"active":"T","session":"2026A","allow_testimony":"F","long_bill_files":[],"bill_files":[{"date":"03/16/2026","lastModified":"03/16/2026 11:25:39 AM","label":"Introduced","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/FBBE1124A20DD3BE87258D7E00618525/$File/140_01.pdf","url_html":""}],"fiscal_note_files":[{"date":"03/17/2026","lastModified":"03/17/2026 04:20:37 PM","label":"FN1","label_detailed":"Initial Fiscal Note","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/FBBE1124A20DD3BE87258D7E00618525/$File/SB140_00.pdf","url_html":""},{"date":"04/01/2026","lastModified":"04/01/2026 03:10:33 PM","label":"FN2","label_detailed":"First Revised Fiscal Note","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/FBBE1124A20DD3BE87258D7E00618525/$File/SB140_r1.pdf","url_html":""}],"research_note_files":[],"budget_staff_analysis_files":[], "preamended_files":[],"committee_report_files":[],"updated_bill_summary_files":[],"demographic_note_files":[],"GHG_report_files":[],"bill_summary":"<html><body><p> The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, a prescription drug that is:<br/></p><p><ul><li>Designated as a drug for a rare disease or condition by the food and drug administration (FDA) of the federal department of health and human services; or</li><li>A licensed biological product that is derived from human whole blood or plasma as indicated on product labeling approved by the FDA.<i>(Note: This summary applies to this bill as introduced.)</i></p></body></html>","amendment_files":[],"session_laws_files":"","votes":[]}